Catalyst Wire Dossier Catalyst Wire Dossier

SRN001

· siRNAgen Therapeutics Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SRN001, covering 2026-02-12 to 2026-02-12. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SRN001 in Healthy Korean and Caucasian Adult Males [Phase 1]

See pricing